- Lower volatility than the market (beta -1.06)
- High gross margin of 93.1%
- Low bankruptcy risk (Altman Z-Score: 9.35)
Evaluation of Madrigal Pharmaceuticals, Inc. stock downgraded after the last trading session
(Updated on Jul 13, 2026)
The Madrigal Pharmaceuticals, Inc. stock price fell by -1.06% on the last day (Monday, 13th Jul 2026) from $536.70 to $531.00. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.47% from a day low at $526.14 to a day high of $539.15. The price has risen in 6 of the last 10 days and is up by 3.58% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 288 thousand shares were bought and sold for approximately $152.86 million.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Madrigal Pharmaceuticals, Inc. stock with a 90% probability to be traded between $450.76 and $563.63 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
MDGL Signals & Forecast
The Madrigal Pharmaceuticals, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $542.29. On a fall, the stock will find some support from the long-term average at approximately $508.92. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -6.08%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Madrigal Pharmaceuticals, Inc. stock
Madrigal Pharmaceuticals, Inc. finds support from accumulated volume at $527.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $13.01 between high and low, or 2.47%. For the last week, the stock has had daily average volatility of 4.45%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MDGL) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Madrigal Pharmaceuticals, Inc. to open at $532.10, and during the day (based on 14 day Average True Range), to move between $520.20 and $541.80, which gives a possible trading interval of +/-$21.60 (+/-4.15%) up or down from last closing price. If Madrigal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 4.15% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $527.28 (0.70%) than the resistance at $534.86 (0.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Madrigal Pharmaceuticals, Inc. stock A Buy?
Madrigal Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-1.006
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $532.10 ( 0.207%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
MDGL Performance
Trading levels for MDGL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 545.11 | 2.66% |
| R2 | 540.14 | 1.72% |
| R1 | 537.07 | 1.14% |
| Price | 531.00 | |
| S1 | 527.13 | -0.729% |
| S2 | 524.06 | -1.31% |
| S3 | 519.09 | -2.24% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 565.40 | 6.48% |
| R2 | 539.73 | 1.64% |
| R1 | 534.86 | 0.727% |
| Price | 531.00 | |
| S1 | 527.28 | -0.701% |
| S2 | 512.65 | -3.46% |
| S3 | 505.75 | -4.76% |
FAQ
Click here for our free guide on how to buy Madrigal Pharmaceuticals, Inc. Stock.
Buy MDGL